|
|
| Product Name: | URB937 | | Synonyms: | URB937;Cyclohexylcarbamic acid 3′–carbamoyl–6–hydroxybiphenyl–3–yl ester;3'-Carbamoyl-6-hydroxybiphenyl-3-yl cyclohexylcarbamate;Carbamic acid, N-cyclohexyl-, 3'-(aminocarbonyl)-6-hydroxy[1,1'-biphenyl]-3-yl ester;3'-Carbamoyl-6-hydroxy-[1,1'-biphenyl]-3-yl cyclohexylcarbamate;FAAH,URB 937,Inhibitor,URB937,low,toxicity,inhibit,Fatty acid amide hydrolase,OEA,URB-937;3'-Carbamoyl-6-hydroxy-[1,1'-biphenyl]-3-yl cyclohexylcarbamate | | CAS: | 1357160-72-5 | | MF: | C20H22N2O4 | | MW: | 354.4 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 1357160-72-5.mol |  |
| | URB937 Chemical Properties |
| Boiling point | 562.8±50.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | DMSO: soluble15mg/mL, clear | | pka | 9.08±0.50(Predicted) | | form | powder (1:1 ratio of product to ethanol) | | color | white to beige |
| | URB937 Usage And Synthesis |
| Uses | URB 937 is a potent inhibitor of fatty-acid amide hydrolase (FAAH), an intracellular serine hydrolase responsible for the deactivation of the endocannabinoid anandamide. It is actively extruded from the central nervous system (CNS), and therefore increases anandamide levels exclusively in peripheral tissues. |
| | URB937 Preparation Products And Raw materials |
|